PortView
Kindred Biosciences (KIN) Stock Analysis
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
What Kindred Biosciences does
Kindred Biosciences, Inc. is a biopharmaceutical firm dedicated to the advancement of biological therapies specifically for companion animals. The company maintains an extensive pipeline of innovative biologics, spanning diverse therapeutic categories, underpinned by a robust intellectual property portfolio. Key development programs include treatments for canine atopic dermatitis, utilizing both interleukin-31 and interleukin-4R, as well as KIND-030 to combat parvovirus in dogs. Additionally, KIND-510a targets non-regenerative anemia in cats, while an anti-TNF antibody is being developed for canine inflammatory bowel disease. Further candidates within its biologics portfolio are also under investigation. Established in 2012, Kindred Biosciences is headquartered in Burlingame, California.
Key metrics
ETFs linked to KIN
Broad-market and Healthcare sector ETFs an investor holding Kindred Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how KIN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze KIN in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Kindred Biosciences?
- Kindred Biosciences trades under the ticker KIN on NASDAQ.
- Which exchange is KIN listed on?
- KIN is listed on NASDAQ.
- What sector does Kindred Biosciences operate in?
- Kindred Biosciences is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
- How can PortView help analyze KIN in a portfolio?
- PortView shows KIN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.